SABA GEBREABE: Open Payments
NPI 1932973435 · STAFFORD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$157 in 7 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $121 · 2025 $157
Food & beverage: $157
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $83 |
| Astellas Pharma US Inc | 1 | $30 |
| Axsome Therapeutics, Inc. | 2 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: Rybelsus, Veozah, Wegovy, Auvelity, Ozempic, XIFAXAN.
Industry payments across VA — which companies pay providers there.
